2017
DOI: 10.1038/s41598-017-12111-1
|View full text |Cite
|
Sign up to set email alerts
|

Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression

Abstract: Low-molecular-weight Fucoidan (Oligo-Fucoidan) is a sulfated polysaccharide that has a variety of biological effects and has also been shown to have beneficial health effects. However, the molecular mechanisms underlying the therapeutic effects of Oligo-Fucoidan in patients with cancer remain unclear. Using human colorectal cancer HCT116 cells with (p53+/+) or without (p53−/−) normal p53 expression, we found that Oligo-Fucoidan treatment reduces the occurrence of spontaneous DNA lesions. Etoposide induces doub… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
30
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 35 publications
(30 citation statements)
references
References 62 publications
(62 reference statements)
0
30
0
Order By: Relevance
“…Histograms display the p53 −/− and p53 +/+ cell cycle distributions for the indicated treatment. Likewise, we have found that Oligo-Fucoidan and ETO collaboratively enhanced p53 function and G2/M arrest alongside inhibition of the CDC2/Cyclin B1 pathway [13]. Hence, Oligo-Fucoidan supplementation may improve the chemotherapeutics, especially in the presence of p53.…”
Section: Cisplatin and Oligo-fucoidan Additively Enhance Cancer Cell mentioning
confidence: 72%
See 2 more Smart Citations
“…Histograms display the p53 −/− and p53 +/+ cell cycle distributions for the indicated treatment. Likewise, we have found that Oligo-Fucoidan and ETO collaboratively enhanced p53 function and G2/M arrest alongside inhibition of the CDC2/Cyclin B1 pathway [13]. Hence, Oligo-Fucoidan supplementation may improve the chemotherapeutics, especially in the presence of p53.…”
Section: Cisplatin and Oligo-fucoidan Additively Enhance Cancer Cell mentioning
confidence: 72%
“…These suggest that Fucoidan supplementation may alter cancer immunity that helps disease treatment. We have demonstrated that Oligo-Fucoidan reduces IL-6 and MCP-1/CCL2 expression and secretion in the ETO-treated cancer cells [13]; thus, Oligo-Fucoidan may control autocrine loops in cancer cells and paracrine pathways in the innate and/or adaptive immune systems. By changing the oxidative metabolism and cytokine/chemokine profile of the immune cells and chemotherapeutic cells, different types of Fucoidan may improve therapeutics and disease-free survival and attenuate chemotherapy-related illnesses, distress and/or inflammation in patients.…”
Section: Discussionmentioning
confidence: 85%
See 1 more Smart Citation
“…Its main role is to regulate immune and inflammatory responses and regulate the proliferation and differentiation of tumor cells. 18 IL-6, an immunomodulatory cytokine, has been extensively studied in the field of cancer, and it initiates different signaling pathways leading to tumor proliferation, angiogenesis, and drug resistance. Previous studies showed that IL-6 can initiate EMT processes and promote the migration and metastasis of squamous cell carcinoma of the head and neck through activating the downstream PI3-K/Akt/mTOR and MAPK/ERK signaling pathways by upregulating p70S6K.…”
Section: Discussionmentioning
confidence: 99%
“…All these studies tried to investigate fucoidans molecular mechanisms in relation to their chemical structure and physicochemical properties. Therefore, different hypotheses were suggested for each activity, such as anti-tumor [31,[38][39][40], anti-coagulant [41,42], anti-viral [43,44] and anti-inflammatory activity [45,46]. These investigations revealed that various factors are relevant, such as molecular weight, sulfation pattern, sulfate content and monomeric composition [47][48][49].…”
mentioning
confidence: 99%